PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases and Immune Defences Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.\', \'Department of Medical Biology, University of Melbourne, Melbourne, VIC 3010, Australia.\', \'Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia.\', \'Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC 3010, Australia.\', \'Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, VIC 3010, Australia.\', \'Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.\', \'Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.\', \'Department of Mathematics and Statistics, University of New South Wales, Sydney, NSW 2052, Australia.\', \'Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.\', \'WHO Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia.\', \'Drug Discovery Biology, Monash Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.\', \'Department of Biochemistry and Pharmacology, University of Melbourne, Melbourne, VIC 3010, Australia.\', \'Infectious Diseases and Immune Defences Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; tham@wehi.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
  • e210191811810.1073/pnas.2101918118
?:doi
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 33893175
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
is ?:relation_isRelatedTo_publication of
?:title
  • Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all